Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4
Cardiovasc Drugs Ther
.
2015 Dec;29(6):589-592.
doi: 10.1007/s10557-015-6622-5.
Authors
A Malik
1
,
D I Bromage
1
,
Z He
1
,
L Candilio
1
,
A Hamarneh
1
,
S Taferner
1
,
S M Davidson
1
,
D M Yellon
2
Affiliations
1
The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
2
The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
[email protected]
.
PMID:
26482377
PMCID:
PMC4674527
DOI:
10.1007/s10557-015-6622-5
No abstract available
Keywords:
CXCR4; Cardioprotection; Ischaemia-reperfusion injury; SDF-1α; Stromal derived factor.
Grants and funding
MR/K002066/1/MRC_/Medical Research Council/United Kingdom
MR/L002043/1/MRC_/Medical Research Council/United Kingdom
PG/15/52/31598/BHF_/British Heart Foundation/United Kingdom
RG/08/015/26411/BHF_/British Heart Foundation/United Kingdom